eduKateSG · Why Science?
Look again at a familiar blood test: how raw analyser signals, blood-smear images and carefully governed AI may reveal useful patterns while clinicians, validation and regulation protect the patient pathway
A current guide to BloodCounts!, the DeepCBC foundation model, full blood count data, blood-smear imaging, federated learning, clinical validation and health-AI careers.
NRF announced BloodCounts! on 16 June 2026 as an inaugural AI-for-Science Challenge project co-led by Cambridge CARES and Nanyang Technological University.
CARES says the Singapore project will develop a DeepCBC foundation model using rich raw complete/full blood count measurements and supplementary blood-smear images, with NUHS and SingHealth as local hospital partners.
Published research applications include stroke and lung-cancer studies, wider disease-pattern discovery and an open or federated research model. These are research and development aims, not a diagnostic service or medical advice.
Did you know? A full blood count report shows familiar summaries such as haemoglobin, red and white cells and platelets, but the analyser creates much richer raw signals. BloodCounts! asks whether responsibly using that extra information can add clinical value without drawing more blood.
NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment. This guide separates current published facts from practical learning advice. Programme details were checked on 27 October 2026; families and students should recheck the linked official pages before applying, paying or attending.
Chapter index
Chapters 1–9: official project, FBC/CBC, analysers, raw parameters, blood smears, multimodal data, foundation models and agnostic training
- 1. BloodCounts! revisits a routine laboratory test
- 2. CARES and NTU co-lead the Singapore project
- 3. The standard FBC already supports many clinical questions
- 4. Raw analyser data contain more detail than the summary
- 5. Blood smears add visual cell information
- 6. DeepCBC is a foundation model of blood
- 7. Agnostic training avoids one-disease tunnel vision
- 8. Multimodal fusion must preserve missingness
- 9. Hospital data need harmonisation and local calibration
Chapters 10–17: hospital data, federated learning, stroke, lung cancer, fairness, regulation, careers and evidence governance
- 10. Federated learning keeps data in trusted environments
- 11. Stroke studies need timing and pathway clarity
- 12. Lung-cancer studies need a suitable screening context
- 13. Rare-disease research benefits from collaboration
- 14. Fairness depends on population and instrument coverage
- 15. Clinical benefit requires workflow and prospective evidence
- 16. Students can join maths, computing and laboratory medicine
- 17. Keep a BloodCounts! evidence receipt
CHAPTER 1 OF 17 · Read the routine test anew
1. BloodCounts! revisits a routine laboratory test
The complete blood count, also called full blood count in Singapore and the UK, is widely used to measure blood-cell features. The project asks whether raw analyser information usually left outside the standard report can support new research. It uses an existing sample and measurement stream, but additional analysis still needs governance and validation.
A routine full blood count contains familiar summary values and much richer raw instrument data; research can ask whether discarded signals carry reproducible information without turning every pattern into a diagnosis. The chapter develops laboratory-test literacy. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Separate the standard report, raw instrument data and later model output in a diagram. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Extra data do not automatically create clinically useful information.
Try this now
Separate the standard report, raw instrument data and later model output in a diagram. Label the result with the date and the capability “laboratory-test literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Extra data do not automatically create clinically useful information.
CHAPTER 2 OF 17 · Read the routine test anew
2. CARES and NTU co-lead the Singapore project
NRF names Cambridge CARES and NTU as co-leads. CARES’ October 2026 release identifies Professor Weisi Lin and Professor Michael Roberts as leads, with NUHS and SingHealth as local hospital partners. Roles, datasets and outputs should be taken from current official records.
A foundation model of blood can learn across many samples and later tasks, but clinical usefulness depends on diverse populations, calibration, intended use, prospective validation and regulatory review. The chapter develops programme literacy. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Map research, clinical, data and engineering responsibilities among partners. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A partner list does not imply a deployed diagnostic tool.
Field-note prompt
Map research, clinical, data and engineering responsibilities among partners. Label the result with the date and the capability “programme literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A partner list does not imply a deployed diagnostic tool.
CHAPTER 3 OF 17 · Read the routine test anew
3. The standard FBC already supports many clinical questions
An FBC reports measures related to red cells, white cells, haemoglobin and platelets, helping clinicians investigate conditions such as anaemia or infection in context. Results depend on the patient, laboratory ranges, history and other tests. The project does not replace clinical interpretation of the current report.
BloodCounts! combines numerical measurements with blood-smear images, joining laboratory medicine, imaging, mathematics and clinical context inside one carefully governed evidence system. The chapter develops clinical-laboratory literacy. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Build a sample report map showing measurement, reference context and clinician question. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Only qualified professionals can interpret an individual result.
Learning move
Build a sample report map showing measurement, reference context and clinician question. Label the result with the date and the capability “clinical-laboratory literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Only qualified professionals can interpret an individual result.
CHAPTER 4 OF 17 · Read the routine test anew
4. Raw analyser data contain more detail than the summary
Automated instruments record distributions, scatter patterns and other signals while classifying cells. Standard workflows report selected parameters, while richer raw information may be discarded. Research can test whether these signals are reproducible across machines and associated with outcomes beyond known measures.
Federated learning can support collaboration while data remain within trusted environments, yet privacy, governance, harmonisation and site-specific bias still require active management. The chapter develops measurement provenance. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Create a provenance map from instrument event to reported and retained fields. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A hidden instrument pattern is not automatically a disease marker.
Evidence practice
Create a provenance map from instrument event to reported and retained fields. Label the result with the date and the capability “measurement provenance”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A hidden instrument pattern is not automatically a disease marker.
CHAPTER 5 OF 17 · Build the DeepCBC model
5. Blood smears add visual cell information
A blood smear places cells on a slide for microscopic review. NRF notes that a proportion of FBCs at SingHealth are supplemented with smear examination. Images can show morphology that numerical summaries miss, but preparation, staining, scanning and expert labels all introduce variation.
A routine full blood count contains familiar summary values and much richer raw instrument data; research can ask whether discarded signals carry reproducible information without turning every pattern into a diagnosis. The chapter develops medical-imaging data literacy. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Write an image-data card with preparation, scanner, annotation and quality checks. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An image model cannot substitute for validated laboratory and clinical workflows.
Try this now
Write an image-data card with preparation, scanner, annotation and quality checks. Label the result with the date and the capability “medical-imaging data literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: An image model cannot substitute for validated laboratory and clinical workflows.
CARES describes a large model trained on full raw CBC/FBC parameters, supplemented by smear images. Pretraining across many samples may support different later tasks. Each application needs separate evaluation because a representation useful for one condition may be miscalibrated or irrelevant for another.
A foundation model of blood can learn across many samples and later tasks, but clinical usefulness depends on diverse populations, calibration, intended use, prospective validation and regulatory review. The chapter develops foundation-model evaluation. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Define pretraining evidence and two downstream validation plans. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Foundation-model status does not confer clinical approval.
Field-note prompt
Define pretraining evidence and two downstream validation plans. Label the result with the date and the capability “foundation-model evaluation”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Foundation-model status does not confer clinical approval.
CHAPTER 7 OF 17 · Build the DeepCBC model
7. Agnostic training avoids one-disease tunnel vision
The project says the model will be trained without optimisation for one condition, aiming for adaptability. This can reveal broad patterns but also discover correlations unrelated to disease mechanisms. Later studies must define the clinical question, population, outcome and comparator before claiming usefulness.
BloodCounts! combines numerical measurements with blood-smear images, joining laboratory medicine, imaging, mathematics and clinical context inside one carefully governed evidence system. The chapter develops intended-use specification. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Turn an open-ended pattern into a precise intended-use study question. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Exploratory discovery is not a validated screening programme.
Learning move
Turn an open-ended pattern into a precise intended-use study question. Label the result with the date and the capability “intended-use specification”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Exploratory discovery is not a validated screening programme.
CHAPTER 8 OF 17 · Build the DeepCBC model
8. Multimodal fusion must preserve missingness
Not every test has a smear image, and smears may be ordered because something already looked unusual. Combining numerical and visual data must represent this selection process so the model does not treat image availability as a shortcut. Compare modes alone and together, and audit missing-data patterns.
Federated learning can support collaboration while data remain within trusted environments, yet privacy, governance, harmonisation and site-specific bias still require active management. The chapter develops multimodal-model auditing. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Create a modality-availability matrix and test for ordering bias. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Missing modalities are not random by default.
Evidence practice
Create a modality-availability matrix and test for ordering bias. Label the result with the date and the capability “multimodal-model auditing”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Missing modalities are not random by default.
CHAPTER 9 OF 17 · Validate across hospitals
9. Hospital data need harmonisation and local calibration
Different analysers, laboratory procedures, coding systems and patient populations can shift data. CARES describes curation in trusted hospital environments and return of models for local analysis. Harmonisation should preserve site labels, instrument versions and quality controls so performance can be calibrated rather than averaged blindly.
A routine full blood count contains familiar summary values and much richer raw instrument data; research can ask whether discarded signals carry reproducible information without turning every pattern into a diagnosis. The chapter develops multisite validation. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Build a site-and-instrument stratified validation table. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Pooling data does not erase hospital-specific variation.
Try this now
Build a site-and-instrument stratified validation table. Label the result with the date and the capability “multisite validation”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Pooling data does not erase hospital-specific variation.
CHAPTER 10 OF 17 · Validate across hospitals
10. Federated learning keeps data in trusted environments
The international BloodCounts! Consortium uses a federated approach in which models can be trained or evaluated across institutions without centralising all raw data. This reduces some transfer risk, but model updates can still leak information and sites need compatible definitions, security and governance.
A foundation model of blood can learn across many samples and later tasks, but clinical usefulness depends on diverse populations, calibration, intended use, prospective validation and regulatory review. The chapter develops privacy-preserving collaboration. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Draw a federated workflow with local data, shared updates and audit controls. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Federation is not automatic privacy or equivalence.
Field-note prompt
Draw a federated workflow with local data, shared updates and audit controls. Label the result with the date and the capability “privacy-preserving collaboration”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Federation is not automatic privacy or equivalence.
CHAPTER 11 OF 17 · Validate across hospitals
11. Stroke studies need timing and pathway clarity
CARES lists stroke as an initial application. A study should define whether the goal is risk prediction, acute support, prognosis or another question, along with the timing of the blood test and clinical comparator. Retrospective signals need prospective evaluation before they can change care.
BloodCounts! combines numerical measurements with blood-smear images, joining laboratory medicine, imaging, mathematics and clinical context inside one carefully governed evidence system. The chapter develops clinical-study design. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Write a stroke-study intended-use statement with time horizon and decision. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A statistical association does not diagnose or predict an individual stroke.
Learning move
Write a stroke-study intended-use statement with time horizon and decision. Label the result with the date and the capability “clinical-study design”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A statistical association does not diagnose or predict an individual stroke.
CHAPTER 12 OF 17 · Validate across hospitals
12. Lung-cancer studies need a suitable screening context
The project also names lung-cancer studies. Evaluation should specify population, disease stage, reference standard and what action a model result would trigger. Sensitivity, specificity, calibration, false positives and missed cases carry different consequences. Compare with current pathways rather than testing the model in isolation.
Federated learning can support collaboration while data remain within trusted environments, yet privacy, governance, harmonisation and site-specific bias still require active management. The chapter develops screening-evidence literacy. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Build a screening-evidence table with benefits, harms and follow-up. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Research signals do not establish a recommended cancer-screening test.
Evidence practice
Build a screening-evidence table with benefits, harms and follow-up. Label the result with the date and the capability “screening-evidence literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Research signals do not establish a recommended cancer-screening test.
CHAPTER 13 OF 17 · Protect patients and careers
13. Rare-disease research benefits from collaboration
Open and federated models may help rare-disease research where one hospital has few examples. Small samples still produce wide uncertainty, and phenotype definitions may differ. Researchers should report confidence intervals, external validation and whether the model genuinely adds evidence rather than memorising a few cases.
A routine full blood count contains familiar summary values and much richer raw instrument data; research can ask whether discarded signals carry reproducible information without turning every pattern into a diagnosis. The chapter develops rare-disease methods literacy. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Design a rare-condition evaluation with uncertainty and leave-one-site-out testing. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: International sample aggregation does not guarantee representativeness.
Try this now
Design a rare-condition evaluation with uncertainty and leave-one-site-out testing. Label the result with the date and the capability “rare-disease methods literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: International sample aggregation does not guarantee representativeness.
CHAPTER 14 OF 17 · Protect patients and careers
14. Fairness depends on population and instrument coverage
CARES says Singapore partners add population diversity to an international consortium. Fair evaluation should examine age, sex, ancestry, clinical setting, analyser and relevant health conditions, with sample sizes and calibration reported. Differences require investigation rather than automatic correction or biological storytelling.
A foundation model of blood can learn across many samples and later tasks, but clinical usefulness depends on diverse populations, calibration, intended use, prospective validation and regulatory review. The chapter develops health-AI fairness auditing. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Create a subgroup audit with measurement and selection explanations. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A diverse dataset can still contain underrepresented groups and biased labels.
Field-note prompt
Create a subgroup audit with measurement and selection explanations. Label the result with the date and the capability “health-AI fairness auditing”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A diverse dataset can still contain underrepresented groups and biased labels.
CHAPTER 15 OF 17 · Protect patients and careers
15. Clinical benefit requires workflow and prospective evidence
A useful model must deliver information at the right time, integrate with laboratory and clinical systems and improve a decision without creating excessive alerts or delay. Prospective studies, human-factors work and post-deployment monitoring examine performance in the real pathway. Clinicians remain accountable for patient care.
BloodCounts! combines numerical measurements with blood-smear images, joining laboratory medicine, imaging, mathematics and clinical context inside one carefully governed evidence system. The chapter develops clinical-workflow evaluation. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Map model output to reviewer, action, fallback and monitoring. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Retrospective model accuracy is not demonstrated patient benefit.
Learning move
Map model output to reviewer, action, fallback and monitoring. Label the result with the date and the capability “clinical-workflow evaluation”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Retrospective model accuracy is not demonstrated patient benefit.
CHAPTER 16 OF 17 · Protect patients and careers
16. Students can join maths, computing and laboratory medicine
The project combines mathematics, computer science, bioinformatics, imaging, haematology, oncology, neurology and clinical informatics. Students can learn from de-identified teaching datasets and focus on calibration, uncertainty and ethics. Current institutions control qualifications, data access and professional practice.
Federated learning can support collaboration while data remain within trusted environments, yet privacy, governance, harmonisation and site-specific bias still require active management. The chapter develops health-data career preparation. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Plan a safe teaching analysis comparing a simple baseline with a calibrated model. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Educational analysis provides no basis for interpreting personal blood tests.
Evidence practice
Plan a safe teaching analysis comparing a simple baseline with a calibrated model. Label the result with the date and the capability “health-data career preparation”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Educational analysis provides no basis for interpreting personal blood tests.
CHAPTER 17 OF 17 · Protect patients and careers
17. Keep a BloodCounts! evidence receipt
Archive the official project edition, hospital and analyser, consent and governance basis, data dictionary, smear workflow, model version, training scheme, intended use, validation, subgroup results, human review, regulatory status and monitored outcomes. This separates research promise from clinical evidence.
A routine full blood count contains familiar summary values and much richer raw instrument data; research can ask whether discarded signals carry reproducible information without turning every pattern into a diagnosis. The chapter develops evidence governance. Keep the official scope, input version, method, raw evidence, uncertainty, review and next decision together. That receipt shows what the model suggested, what the real-world check found and where the claim must stop. NRF and CARES describe the project; NUHS, SingHealth, NTU, Cambridge, data-governance bodies, clinicians and regulators control data access, research use, clinical decisions and deployment.
Put this into practice by turning the idea into a small, reviewable action: Create a versioned test–data–model–study–decision lineage. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Current hospitals, ethics bodies and regulators control clinical use.
Try this now
Create a versioned test–data–model–study–decision lineage. Label the result with the date and the capability “evidence governance”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Current hospitals, ethics bodies and regulators control clinical use.
BloodCounts! evidence pathway
| Stage | Evidence to keep | Boundary to retain |
|---|---|---|
| Routine test | Raw analyser signals, summary values and quality control | More variables do not equal a diagnosis |
| Multimodal model | Numerical data, smear images, versions and uncertainty | A foundation model needs task-specific validation |
| Hospital study | Population, intended use, comparator and prospective evidence | Retrospective association may not improve care |
| Clinical pathway | Human review, regulation, monitoring and patient benefit | Research output is not medical advice |
Science learning becomes useful when a student can show where a claim came from, why it applies and where it stops. Continue with the eduKate Science Learning Hub, compare choices in the Education Hub, and connect developing capabilities to education and career pathways. Families looking for science tuition or a science tutor can use the same evidence questions: what will the learner practise, what feedback will they receive, and how will progress be shown?
Look again at a familiar blood test: how raw analyser signals, blood-smear images and carefully governed AI may reveal useful patterns while clinicians, validation and regulation protect the patient pathway The happiest outcome is not a perfect label. It is a learner who can ask a sharper question, work safely, notice honestly, revise with feedback and stay curious about what comes next.
Primary sources and verification date
Source status checked 27 October 2026. Programme rules, dates, eligibility, access and participation routes can change; use the linked official owner for the current edition.
- NRF AI-for-Science inaugural projects press release — Official 16 June 2026 description of the S$120 million initiative and eight inaugural Challenge projects.
- NRF Resources — Official resource index for current NRF releases and publications.
- Cambridge CARES: BloodCounts! research — Official project description, DeepCBC research structure, Singapore partners, federated learning and intended validation.
- Cambridge CARES: BloodCounts! 26 October 2026 release — Official current release naming project leads, hospital partners, data contribution and clinical research aims.
- NUHS Laboratory Medicine — Official institutional context for laboratory medicine; current patient testing and clinical information belong to NUHS.
